# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-272375
Filing Date
2025-11-07
Accepted
2025-11-07 16:15:06
Documents
78
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rkda-20250930.htm iXBRL | 10-Q | 2783795
2 | EX-31.1 | rkda-ex31_1.htm | EX-31.1 | 14878
3 | EX-31.2 | rkda-ex31_2.htm | EX-31.2 | 14872
4 | EX-32.1 | rkda-ex32_1.htm | EX-32.1 | 9862
5 | EX-32.2 | rkda-ex32_2.htm | EX-32.2 | 9636
| Complete submission text file | 0001193125-25-272375.txt |  | 11863693

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rkda-20250930.xsd | EX-101.SCH | 1593429
81 | EXTRACTED XBRL INSTANCE DOCUMENT | rkda-20250930_htm.xml | XML | 2487721

Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37383 | Film No.: 251462833
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)